Institut für Pharmazeutische Technologie, Technische Universität Braunschweig, Braunschweig, Germany.
J Ocul Pharmacol Ther. 2012 Jun;28(3):271-7. doi: 10.1089/jop.2011.0124. Epub 2011 Dec 23.
Drugs from ophthalmic formulations are mainly absorbed into the eye via the corneal route. However, little is known about drug metabolism during the transcorneal passage. The objective of this study was to determine the mRNA expression of phase I and II isoenzymes in human corneal epithelial tissue, corneal cell lines, and a tissue-engineered cornea equivalent (a hemicornea construct) as in vitro model for drug absorption studies.
The reverse transcription polymerase chain reaction was used to profile the mRNA expression of 10 cytochrome P450 enzymes (CYP) and seven phase II enzymes in the three human corneal cell lines and the hemicornea construct. The human corneal epithelial cell line (HCE-T), human corneal keratocyte cell line (HCK-Ca) and human corneal endothelial cell line (HENC) were used. Human liver tissue, human corneal epithelium from donor corneas, and the human colon adenocarcinoma cell line Caco-2 were also investigated.
All the phase I and II mRNAs were expressed in the human liver tissue. The Caco-2 cell line showed an expression pattern similar to the liver tissue, although the signals for CYP1A2 and CYP3A4 were absent. In the case of the donor human corneal epithelium, all the detected phase I mRNAs had lower levels than did the liver tissue. By contrast, the phase II mRNA expression pattern was heterogeneous to the liver tissue. The expression patterns in the three human corneal cell lines were comparable, although the signals for a few phase I enzymes and N-acetyltransferase (NAT2) mRNAs were only detectable in the HCE-T. In the hemicornea construct, all the investigated phase I and II mRNA (except for CYP1A2, CYP2B6, CYP2C19, and NAT2) were expressed.
Overall, the mRNA expressions of the tested phase I and phase II enzymes in the hemicornea construct and the three corneal cell lines correlated well with the expression patterns of the ex vivo human corneal epithelium.
眼部制剂中的药物主要通过角膜途径吸收到眼睛中。然而,对于跨角膜过程中的药物代谢知之甚少。本研究的目的是确定人角膜上皮组织、角膜细胞系和组织工程角膜等效物(半角膜构建体)中 I 相和 II 相同工酶的 mRNA 表达,作为药物吸收研究的体外模型。
使用逆转录聚合酶链反应分析三种人角膜细胞系和半角膜构建体中 10 种细胞色素 P450 酶(CYP)和 7 种 II 相酶的 mRNA 表达。使用人角膜上皮细胞系(HCE-T)、人角膜成纤维细胞系(HCK-Ca)和人角膜内皮细胞系(HENC)。还研究了人肝组织、供体角膜上皮和人结肠腺癌细胞系 Caco-2。
所有 I 相和 II 相 mRNA 均在人肝组织中表达。Caco-2 细胞系的表达模式与肝组织相似,尽管 CYP1A2 和 CYP3A4 的信号缺失。在供体人角膜上皮的情况下,所有检测到的 I 相 mRNA 的水平均低于肝组织。相比之下,II 相 mRNA 的表达模式与肝组织不同。三种人角膜细胞系的表达模式相似,尽管少数 I 相酶和 N-乙酰转移酶(NAT2)mRNA 的信号仅在 HCE-T 中可检测到。在半角膜构建体中,所有研究的 I 相和 II 相 mRNA(除 CYP1A2、CYP2B6、CYP2C19 和 NAT2 外)均有表达。
总体而言,半角膜构建体和三种角膜细胞系中测试的 I 相和 II 相酶的 mRNA 表达与离体人角膜上皮的表达模式相关。